Cleopatra’s Survival Impact in HER2+ Metastatic Breast Cancer

For more than a decade, the Cleopatra regimen reshaped outcomes in HER2-positive metastatic breast cancer, delivering unprecedented survival benefits and redefining what long-term disease control could look like.